Skip to main content

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Patient Concerns About Deprescribing: How to Address Them

October 20, 2025

HMP · Patient Concerns About Deprescribing: How to Address Them

Welcome to Schizophrenia Knowledge Base

This website is intended for healthcare professionals in the United States.

Yes, I am a US healthcare professional
No, I am not a US healthcare professional

Greg Mattingly, MD shares effective communication strategies with patients and caregivers.

Related Content

Patient Case Studies: Successful Deprescription of Anticholinergics
Can Anticholinergic Medications Make Movement Disorders Worse?
Patient Concerns About Deprescribing: How to Address Them
Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?
How Do Emerging Muscarinic Agonists Like KarXT Affect Anticholinergic Use?
How to Taper Anticholinergic Medications Safely
What’s the Role of Amantadine in Anticholinergic Deprescription?
© 2025 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy